AU2003264861A1 - Novel crystalline forms of celecoxib - Google Patents

Novel crystalline forms of celecoxib

Info

Publication number
AU2003264861A1
AU2003264861A1 AU2003264861A AU2003264861A AU2003264861A1 AU 2003264861 A1 AU2003264861 A1 AU 2003264861A1 AU 2003264861 A AU2003264861 A AU 2003264861A AU 2003264861 A AU2003264861 A AU 2003264861A AU 2003264861 A1 AU2003264861 A1 AU 2003264861A1
Authority
AU
Australia
Prior art keywords
celecoxib
crystalline forms
novel crystalline
novel
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264861A
Inventor
Dasari Muralidhara Reddy
Bandi Parthasaradhi Reddy
Rapolu Raji Reddy
Kura Rathnakar Reddy
Kesireddy Subash Chander Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003264861A1 publication Critical patent/AU2003264861A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003264861A 2003-08-08 2003-08-08 Novel crystalline forms of celecoxib Abandoned AU2003264861A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000267 WO2005014546A1 (en) 2003-08-08 2003-08-08 Novel crystalline forms of celecoxib

Publications (1)

Publication Number Publication Date
AU2003264861A1 true AU2003264861A1 (en) 2005-02-25

Family

ID=34131130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264861A Abandoned AU2003264861A1 (en) 2003-08-08 2003-08-08 Novel crystalline forms of celecoxib

Country Status (2)

Country Link
AU (1) AU2003264861A1 (en)
WO (1) WO2005014546A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528568A (en) * 2005-01-31 2008-07-31 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Celecoxib of type IV crystals
WO2011055233A2 (en) 2009-11-03 2011-05-12 Actavis Group Ptc Ehf Improved process for preparing celecoxib polymorph

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU760888B2 (en) * 1999-01-14 2003-05-22 Merck Frosst Canada & Co. Synthesis of 4-((5-substituted or unsubstituted phenyl) -3-substituted -1H-pyrazol -1-yl) benzenesulfonamides
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)

Also Published As

Publication number Publication date
WO2005014546A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
AU2003230192A1 (en) Novel crystalline forms of aripiprazole
AU2003291579A1 (en) Yield improvement
AU2003239644A1 (en) Crystallization of sugars
AU2003273083A1 (en) Compositions for the improvement of obesity
AU2003238671A1 (en) Novel crystalline forms of s-omeprazole magnesium
AU2003245029A1 (en) Novel crystalline forms of donepezil hydrochloride
AU2003245027A1 (en) Novel crystalline forms of ziprasidone hydrochloride
AU2003232719A1 (en) Novel crystalline forms of valacyclovir hydrochloride
AU2003222439A1 (en) Novel crystalline forms of tegaserod maleate
AU2003230193A1 (en) Novel crystalline forms of candesartan cilexetil
AU2003217438A1 (en) Novel crystalline forms of levetiracetam
AU2003264861A1 (en) Novel crystalline forms of celecoxib
AU2003228950A1 (en) Oocyte recording chamber
AU2003217437A1 (en) Novel crystalline forms of lamotrigine
AU2003257541A1 (en) Novel crystals
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003238668A1 (en) Novel crystalline forms of valdecoxib
AU2003238669A1 (en) Novel crystalline forms of parecoxib sodium
AU2002251329A1 (en) Novel crystalline forms of celecoxib and other compounds
AU2003263582A1 (en) Process for the manufacture of rofecoxib
AU2003238678A1 (en) Novel crystalline forms of sumatriptan succinate
AU2003230194A1 (en) Novel crystalline forms of gatifloxacin
AU2003262704A1 (en) Synthesis of gatifloxacin
EP1486485A4 (en) Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
AU2003223105A1 (en) Novel crystalline forms of (s)-citalopram oxalate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase